Advaita Corporation

46099 Five mile Road Array
Plymouth, MI 48170

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $4.49MM
First Award Date 03/01/09
Most Recent Award Date 06/01/17

Key Personnel

Last Name Name Awards Contact
Draghici Sorin Draghici 4
Hartman John Richard Hartman 2
VOICHITA CALIN VOICHITA 4 Message

9 Awards Won

Phase 1 SBIR

Agency: National Science Foundation
Topic: BT
Budget: 06/01/17 - 11/30/17

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to develop an analysis software package to significantly reduce health care costs while simultaneously improving patient care by helping select the correct treatment for each patient. Every year an estimated of 1.4 million women undergo unne...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-09-220
Budget: 05/01/16 - 04/30/17

DESCRIPTION (provided by applicant): Once heralded as the holy grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-09-220
Budget: 05/01/15 - 04/30/16

DESCRIPTION (provided by applicant): Once heralded as the holy grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-09-220
Budget: 05/01/14 - 04/30/15

DESCRIPTION (provided by applicant): Once heralded as the holy grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-09-220
Budget: 09/10/13 - 04/09/14

DESCRIPTION (provided by applicant): Once heralded as the holy grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-09-221
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): Once heralded as the Holy Grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-09-221
Budget: 06/01/12 - 05/31/13

DESCRIPTION (provided by applicant): Once heralded as the Holy Grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-09-221
Budget: 09/01/11 - 05/31/12

DESCRIPTION (provided by applicant): Once heralded as the Holy Grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though such high-throughput comparisons have become rela...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PAR-07-161
Budget: 03/01/09 - 08/31/10

DESCRIPTION (provided by applicant): A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions on various regulatory pathways. Currently, a statistical approach is universally used to identify the most relevant pathways in a given experiment. This approach onl...